Literature DB >> 22447656

Crystal structure of agkisacucetin, a Gpib-binding snake C-type lectin that inhibits platelet adhesion and aggregation.

Yongxiang Gao1, Honghua Ge, Hongkai Chen, Heng Li, Yiwei Liu, Lan Chen, Xiaoyi Li, Jing Liu, Liwen Niu, Maikun Teng.   

Abstract

Agkisacucetin is a snake C-type lectin isolated from the venom of Agkistrodon acutus (A. acutus). It binds specifically to the platelet glycoprotein (GP) Ib and prevents the von Willebrand factor (VWF) accessing it. We determined the crystal structure of agkisacucetin to 1.9Å resolution. The structure of agkisacucetin has an (αβ) fold similar to another GPIb-binding protein, flavocetin-A, but lacks the C-terminal cysteine in the β-subunit, does not form (βα)(4) tetramers, and does not cluster GPIbs, like flavocetin-A.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22447656     DOI: 10.1002/prot.24060

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  9 in total

1.  Platelet Protein Disulfide Isomerase Promotes Glycoprotein Ibα-Mediated Platelet-Neutrophil Interactions Under Thromboinflammatory Conditions.

Authors:  Jing Li; Kyungho Kim; Si-Yeon Jeong; Joyce Chiu; Bei Xiong; Pavel A Petukhov; Xiangrong Dai; Xiaoyi Li; Robert K Andrews; Xiaoping Du; Philip J Hogg; Jaehyung Cho
Journal:  Circulation       Date:  2019-03-05       Impact factor: 29.690

2.  Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura.

Authors:  Liang Zheng; Yingying Mao; Mohammad S Abdelgawwad; Nicole K Kocher; Mandy Li; Xiangrong Dai; Benjamin Li; X Long Zheng
Journal:  Blood Adv       Date:  2016-11-29

Review 3.  The chemistry of snake venom and its medicinal potential.

Authors:  Ana L Oliveira; Matilde F Viegas; Saulo L da Silva; Andreimar M Soares; Maria J Ramos; Pedro A Fernandes
Journal:  Nat Rev Chem       Date:  2022-06-10       Impact factor: 34.571

4.  Structure of the platelet glycoprotein Ib receptor in complex with a novel antithrombotic agent.

Authors:  Jing Wang; Yongxiang Gao; Lan Chen; Yugang Guo; Siyi Hu; Liansheng Cheng; Weihua Xiao; Jiyuan Ke; Zhongliang Zhu; Liwen Niu
Journal:  Blood       Date:  2021-02-11       Impact factor: 22.113

5.  In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIbα.

Authors:  Benjamin Xiaoyi Li; Xiangrong Dai; Xiaohong Ruby Xu; Reheman Adili; Miguel Antonio Dias Neves; Xi Lei; Chuanbin Shen; Guangheng Zhu; Yiming Wang; Hui Zhou; Yan Hou; Tiffany Ni; Yfke Pasman; Zhongqiang Yang; Fang Qian; Yanan Zhao; Yongxiang Gao; Jing Liu; Maikun Teng; Alexandra H Marshall; Eric G Cerenzia; Mandy Lokyee Li; Heyu Ni
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

6.  Crystallization and preliminary X-ray analysis of the C-type lectin domain of the spicule matrix protein SM50 from Strongylocentrotus purpuratus.

Authors:  Puneet Juneja; Ashit Rao; Helmut Cölfen; Kay Diederichs; Wolfram Welte
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-01-22       Impact factor: 1.072

7.  Balancing the Expression and Production of a Heterodimeric Protein: Recombinant Agkisacutacin as a Novel Antithrombotic Drug Candidate.

Authors:  Yugang Guo; Jing Wu; Hao Jia; Wei Chen; Changsheng Shao; Lei Zhao; Jiajia Ma; Rui Li; Yongjun Zhong; Fang Fang; Dong Wang; Jie Sun; Fang Qian; Xiangrong Dai; Guohui Zhang; Zhigang Tian; Benjamin Xiaoyi Li; Weihua Xiao
Journal:  Sci Rep       Date:  2015-07-06       Impact factor: 4.379

Review 8.  Structurally Robust and Functionally Highly Versatile-C-Type Lectin (-Related) Proteins in Snake Venoms.

Authors:  Johannes A Eble
Journal:  Toxins (Basel)       Date:  2019-03-01       Impact factor: 4.546

9.  A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury.

Authors:  Ting-Ting Li; Man-Li Fan; Shi-Xiang Hou; Xiao-Yi Li; Devin M Barry; Hui Jin; Sheng-Yong Luo; Feng Kong; Lit-Fui Lau; Xiang-Rong Dai; Guo-Hui Zhang; Lan-Lan Zhou
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.